Singapore markets closed

Sino Biopharmaceutical Limited (1177.HK)

HKSE - HKSE Delayed Price. Currency in HKD
Add to watchlist
3.710+0.020 (+0.54%)
At close: 04:08PM HKT
Currency in HKD

Valuation measures4

Market cap (intra-day) 69.42B
Enterprise value 65.39B
Trailing P/E 8.67
Forward P/E 16.58
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)2.35
Price/book (mrq)2.11
Enterprise value/revenue 2.36
Enterprise value/EBITDA 5.60

Trading information

Stock price history

Beta (5Y monthly) 0.47
52-week change 3-37.88%
S&P500 52-week change 3-15.36%
52-week high 36.300
52-week low 33.580
50-day moving average 34.139
200-day moving average 34.680

Share statistics

Avg vol (3-month) 336.05M
Avg vol (10-day) 343.61M
Shares outstanding 518.81B
Implied shares outstanding 6N/A
Float 88.53B
% held by insiders 147.86%
% held by institutions 114.18%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.12
Forward annual dividend yield 43.25%
Trailing annual dividend rate 30.08
Trailing annual dividend yield 32.25%
5-year average dividend yield 40.79
Payout ratio 413.00%
Dividend date 3N/A
Ex-dividend date 406 Sept 2022
Last split factor 23:2
Last split date 320 Jul 2020

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)30 Jun 2022

Profitability

Profit margin 29.06%
Operating margin (ttm)15.77%

Management effectiveness

Return on assets (ttm)4.51%
Return on equity (ttm)29.08%

Income statement

Revenue (ttm)27.7B
Revenue per share (ttm)1.48
Quarterly revenue growth (yoy)6.80%
Gross profit (ttm)21.53B
EBITDA 5.17B
Net income avi to common (ttm)8.05B
Diluted EPS (ttm)0.430
Quarterly earnings growth (yoy)-85.40%

Balance sheet

Total cash (mrq)15.67B
Total cash per share (mrq)0.85
Total debt (mrq)12.02B
Total debt/equity (mrq)31.02
Current ratio (mrq)1.55
Book value per share (mrq)1.63

Cash flow statement

Operating cash flow (ttm)6.98B
Levered free cash flow (ttm)8.05B